HERRERA BUCIO, RAFAEL
QUÍMICA · Nivel 1
Prof en Universidad Michoacana de San Nicolás de Hidalgo
Información*
| Nombre | RAFAEL HERRERA BUCIO |
|---|---|
| Área | BIOLOGÍA Y QUÍMICA |
| Campo | QUÍMICA |
| Disciplina | QUÍMICA ORGÁNICA |
| Especialidad | SINTESIS ORGANICA |
| CVU | 30925 |
| Institución | |
|---|---|
| Dependencia | INSTITUTO DE INVESTIGACIONES QUIMICO-BIOLOGICAS |
| Entidad | MICHOACAN DE OCAMPO |
| Nivel | 1 |
| Vigencia | Inicio: 01/01/2022 |
| Fin: 31/12/2026 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2026
- DE LA NATURALEZA AL DISEÑO MOLECULAR: CARACTERIZACIÓN ESTRUCTURAL Y ENERGÉTICA DE UN DERIVADO DE MEDICARPINA Actas del Congreso de Investigación, Desarrollo e Innovación
- Enhanced Inhibition of Trametes versicolor by Structurally Modified Medicarpin: In Vitro Evaluation and In Silico Insights into Laccase Binding International Journal of Molecular Sciences
- Dual Inhibition of COX‐2/5‐LOX Through Novel Hybrids of NSAIDs and Peptides: Insights from Molecular Dynamics Simulation and Per‐Residue Decomposition ChemistryOpen
- 2025
- Pyrolysis of Persea americana Pruning Residues: Kinetic and Thermodynamic Analyses Processes
- Primary Constitution and Proximal Analysis of Three Fabaceae by the Thermogravimetric and Chemical Methods for Their Potential Use as Bioenergy Processes
- Molecular Docking and Dynamics of a Series of Aza-Heterocyclic Compounds Against Effector Protein NleL
- Polymorph Selection and Derivatization in Enantiomerically Pure Medicarpin: Crystallographic and Computational Insights Molecules
- Chronic administration of tetrahydrofuran extracts of Cochlospermum vitifolium (Wild) Sprengel in a mouse diabetes model: Hypoglycemic, antioxidant, and genoprotective effects Biomedicine & Pharmacotherapy
- 2024
- Synthesis of Peptide–Nonsteroidal Anti-Inflammatory Drug Hybrid Compounds and Their Selectivity in Inhibiting the Dual Cyclooxygenase-2 (COX)–5-Lipoxygenase (LOX) System: A Docking and Molecular Dynamics Study
- Molecular Docking and Dynamics of a Series of Aza-Heterocyclic Compounds Against Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus